文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

SARS-CoV2相关肺炎ICU患者急性肾损伤:一项回顾性多中心研究

Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study.
PubMed 文献 · Ann Intensive Care · 2021-05-31
一句话结论在SARS-CoV2相关肺炎ICU患者中,急性肾损伤(AKI)发生率为52%,主要由既往慢性肾脏病和生命支持治疗驱动,AKI与28天死亡率校正后关系不明确。

该回顾性观察研究纳入巴黎四所大学附属医院的379例SARS-CoV2相关肺炎ICU患者,按KDIGO指南定义AKI。52%患者发生AKI(15%为1期,12%为2期,25%为3期)。慢性肾脏病(OR 7.41;95%CI 2.98-18.4)、第1天需要有创机械通气(OR 4.83;95%CI 2.26-10.3)、第1天需要血管升压药(OR 2.1;95%CI 1.05-4.21)与AKI风险增加相关。队列28天死亡率为26.4%,AKI患者死亡率更高(37.4% vs 14.7%,P<0.001),但校正后AKI(HR 1.35;95%CI 0.78-2.32)及AKI分期均与死亡率无关。

要点

  • 379例SARS-CoV2相关肺炎ICU患者中52%发生AKI,其中25%为3期。
  • 慢性肾脏病(OR 7.41;95%CI 2.98-18.4)、第1天需要有创机械通气(OR 4.83;95%CI 2.26-10.3)、第1天需要血管升压药(OR 2.1;95%CI 1.05-4.21)与AKI风险增加相关。
  • AKI患者28天死亡率更高(37.4% vs 14.7%,P<0.001),但校正后AKI(HR 1.35;95%CI 0.78-2.32)及分期与死亡率无关。

适用人群与场景

  • 巴黎四所大学附属医院ICU收治的SARS-CoV2相关肺炎患者,共379例,中位年龄62岁(53-69岁),77%为男性。

诊断标准与关键阈值

  • AKI按KIDGO指南定义。

研究设计与关键结果

  • 回顾性观察研究,纳入巴黎四所大学附属医院的379例SARS-CoV2相关肺炎ICU患者,中位年龄62岁(53-69岁),77%为男性。
  • 52%(n=195)发生AKI,其中1期58例(15%)、2期44例(12%)、3期93例(25%)。
  • 慢性肾脏病(OR 7.41;95%CI 2.98-18.4)、第1天需要有创机械通气(OR 4.83;95%CI 2.26-10.3)、第1天需要血管升压药(OR 2.1;95%CI 1.05-4.21)与AKI风险增加相关。
  • 队列28天死亡率为26.4%,AKI患者死亡率更高(37.4% vs 14.7%,P<0.001)。
  • 校正后AKI与死亡率无关(HR 1.35;95%CI 0.78-2.32);与无AKI相比,1期、2期、3期的HR(95%CI)分别为1.02(0.49-2.10)、1.73(0.81-3.68)、1.42(0.78-2.58)。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在这组SARS-CoV2相关肺炎ICU患者中AKI常见,主要由既往慢性肾脏病和生命支持治疗驱动,其与28天结局的校正后关系不明确。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While acute kidney injury (AKI) is frequent in severe SARS-CoV2-related pneumonia ICU patients, few data are still available about its risk factors.

METHODS: Retrospective observational study performed in four university affiliated hospitals in Paris. AKI was defined according to the KIDGO guidelines. Factors associated with AKI were picked up using multivariable mixed-effects logistic regression. Independent risk factors of day 28 mortality were assessed using Cox model.

RESULTS: 379 patients (median age 62 [53,69], 77% of male) were included. Half of the patients had AKI (n = 195, 52%) including 58 patients (15%) with AKI stage 1, 44 patients (12%) with AKI stage 2, and 93 patients (25% with AKI stage 3). Chronic kidney disease (OR 7.41; 95% CI 2.98-18.4), need for invasive mechanical ventilation at day 1 (OR 4.83; 95% CI 2.26-10.3), need for vasopressors at day 1 (OR 2.1; 95% CI 1.05-4.21) were associated with increased risk of AKI. Day 28 mortality in the cohort was 26.4% and was higher in patients with AKI (37.4 vs. 14.7%, P < 0.001). Neither AKI (HR 1.35; 95% CI 0.78-2.32) nor AKI stage were associated with mortality (HR [95% CI] for stage 1, 2 and 3 when compared to no AKI of, respectively, 1.02 [0.49-2.10], 1.73 [0.81-3.68] and 1.42 [0.78-2.58]).

CONCLUSION: In this large cohort of SARS-CoV2-related pneumonia patients admitted to the ICU, AKI was frequent, mostly driven by preexisting chronic kidney disease and life sustaining therapies, with unclear adjusted relationship with day 28 outcome.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Geri G, Darmon M, Zafrani L, et al. Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study. Ann Intensive Care. 2021. PMID: 34057648. doi:10.1186/s13613-021-00875-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。